By Sabela Ojea
BridgeBio Pharma said Friday it would share next week topline results from the latest phase of its transthyretin amyloid cardiomyopathy heart disease study. Shares of the commercial-stage biopharmaceutical company rose 12% to $20.40 in after-hours trading.
Universal Security Instruments reported higher quarterly and yearly sales. Shares of the home protection solutions company climbed 9.1% to $3.01 in after-hours trading.
BYND Cannasoft Enterprises said it intends to launch an underwritten public offering. Shares of the Israeli-based integrated software and cannabis company dropped 28% to $2.26 in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com
Read the full article here